Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

por Charokopou, M., McEwan, P., Lister, S., Callan, L., Bergenheim, K., Tolley, K., Postema, R., Townsend, R., Roudaut, M.
Publicado 2015

Continued inadequacies in data sources for the evaluation of cancer services.

por Smith, S. J., Muir, K. R., Wolstenholme, J. L., Thornhill, K. G., Zamorski, A., Tolley, K., Logan, R. F., Chilvers, C. E.
Publicado 1997